Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Side Effects and Safety Profile The extensive clinical development program for AOD-9604 included rigorous safety assessment across animal toxicology studies and human trials, providing a comprehensive understanding of the peptides safety profile
Some individuals explore BPC 157 under medical supervision as part of a broader wellness or recovery plan
Every vial is third-party tested by independent laboratories to verify 99% HPLC purity, identity by mass spectrometry, and endotoxin limits by LAL testing, and ships with a batch-specific certificate of analysis the COA for this product is shown in the gallery above and published on our COA page
AOD-9604 is a modified peptide consisting of the last 15 amino acids from the C-terminal region of human growth hormone (specifically amino acids 176-191 with a tyrosine added to the N-terminus for stability)
In Phase 2 detoxification, various enzymes act directly on the toxic substances partially degraded and processed in Phase 1, such as heavy metals and organo-toxins, by binding them with protective compounds, thereby either inactivating the toxins
US$ 22.88
US$ 20.65
US$ 20.98
